SCHEMBL17037340

SCHEMBL17037340

N#Cc1ccc(S(=O)(=O)c2c3ccccc3c(-c3cc4c(-c5ccccc5)nc5ccccc5c4c4ccccc34)c3ccccc23)c2ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
LMNA P02545 3/20 0.40
THRB P10828 1/20 0.40
KDM4E B2RXH2 3/20 0.37
HTT P42858 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
HPGD P15428 1/20 0.36
SLC22A12 Q96S37 6/20 0.33
POLB P06746 2/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
GBA1 P04062 1/20 0.32
ADORA2A P29274 1/20 0.32
DYRK1A Q13627 1/20 0.32
NR1H2 P55055 1/20 0.32
KDM5A P29375 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037773 0.85 ALDH1A1 (0.48) ALDH1A1LMNATHRBKDM4EHTT
SCHEMBL17037341 0.82 GBA1 (0.39) ALDH1A1LMNATHRBKDM4EGBA1
SCHEMBL17034981 0.81 LMNA (0.37) ALDH1A1LMNAKDM4EHPGDMAPT
SCHEMBL18914565 0.77 ALDH1A1 (0.41) ALDH1A1LMNATHRBKDM4EHTT
SCHEMBL17037278 0.77 ALDH1A1 (0.45) ALDH1A1LMNATHRBKDM4EHTT
SCHEMBL17037772 0.74 ADORA2A (0.43) ALDH1A1LMNATHRBKDM4EHTT
SCHEMBL18914760 0.74 ALDH1A1 (0.41) ALDH1A1LMNATHRBKDM4EHTT
SCHEMBL17034984 0.73 LMNA (0.39) ALDH1A1LMNAKDM4EHPGDMAPT
SCHEMBL17034982 0.73 LMNA (0.36) ALDH1A1LMNAKDM4EHPGDMAPT
SCHEMBL18914725 0.72 SLC22A12 (0.39) ALDH1A1LMNATHRBKDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9871208-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-01-16 US disclosed
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2015-08-27 US disclosed
US-20150072961-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS PREMIER RESEARCH INTERNATIONAL, LLC 2015-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150243908-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ALDH1A1 753/4885LMNA 1598/4885THRB 4519/4885
US-20150072961-A1 HIGH PENETRATION PRODRUG COMPOSITIONS AND PHARMACEUTICAL COMPOSITION THEREOF FOR TREATMENT OF PULMONARY CONDITIONS HRH4, HCAR2, PAH ALDH1A1 1724/4885LMNA 1999/4885THRB 4129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.